- Home
- ORI vs EXAS Comparison
ORI vs EXAS Comparison
Compare ORI & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORI
- EXAS
- Stock Information
- Founded
- ORI 1923
- EXAS 1995
- Country
- ORI United States
- EXAS United States
- Employees
- ORI N/A
- EXAS N/A
- Industry
- ORI Property-Casualty Insurers
- EXAS Medical Specialities
- Sector
- ORI Finance
- EXAS Health Care
- Exchange
- ORI Nasdaq
- EXAS Nasdaq
- Market Cap
- ORI 9.4B
- EXAS 9.1B
- IPO Year
- ORI N/A
- EXAS N/A
- Fundamental
- Price
- ORI $38.64
- EXAS $45.60
- Analyst Decision
- ORI Buy
- EXAS Strong Buy
- Analyst Count
- ORI 1
- EXAS 22
- Target Price
- ORI $41.00
- EXAS $66.43
- AVG Volume (30 Days)
- ORI 1.4M
- EXAS 3.8M
- Earning Date
- ORI 07-24-2025
- EXAS 08-06-2025
- Dividend Yield
- ORI 3.00%
- EXAS N/A
- EPS Growth
- ORI 48.63
- EXAS N/A
- EPS
- ORI 3.53
- EXAS N/A
- Revenue
- ORI $8,666,400,000.00
- EXAS $2,939,949,000.00
- Revenue This Year
- ORI $9.05
- EXAS $14.61
- Revenue Next Year
- ORI $5.97
- EXAS $12.71
- P/E Ratio
- ORI $10.96
- EXAS N/A
- Revenue Growth
- ORI 14.20
- EXAS 12.55
- 52 Week Low
- ORI $33.00
- EXAS $38.81
- 52 Week High
- ORI $39.84
- EXAS $72.83
- Technical
- Relative Strength Index (RSI)
- ORI 67.14
- EXAS 44.47
- Support Level
- ORI $35.60
- EXAS $40.55
- Resistance Level
- ORI $38.83
- EXAS $45.45
- Average True Range (ATR)
- ORI 0.45
- EXAS 2.04
- MACD
- ORI 0.29
- EXAS 0.07
- Stochastic Oscillator
- ORI 93.96
- EXAS 63.10
About ORI Old Republic International Corporation
Old Republic International Corp offers a diverse range of specialized insurance products to individuals and institutions. The company operates in two segments: Specialty Insurance and Title Insurance. The Insurances provided by the company includes Automobile Extended Warranty Insurance, Aviation, Commercial Automobile Insurance, Inland Marine, Travel Accident, Workers' Compensation, Financial Indemnity, and others.
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.